rs128626249
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004006.3(DMD):c.5899C>T(p.Arg1967*) variant causes a stop gained change. The variant allele was found at a frequency of 0.000000912 in 1,096,246 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004006.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DMD | ENST00000357033.9 | c.5899C>T | p.Arg1967* | stop_gained | Exon 41 of 79 | 1 | NM_004006.3 | ENSP00000354923.3 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD3 exomes AF: 0.00000552 AC: 1AN: 181045Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 65875
GnomAD4 exome AF: 9.12e-7 AC: 1AN: 1096246Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 361852
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
not provided Pathogenic:4
- -
- -
Based on the understanding of this genetic alteration, it may be amenable to nonsense read-through therapy that is currently available or in clinical trial; This variant is associated with the following publications: (PMID: 32559196, 31727011, 31919629, 30833962, 27363342, 19065519, 19937601, 19959795, 8401539, 18652600, 25525159, 15319032) -
- -
Duchenne muscular dystrophy Pathogenic:2Uncertain:1
The observed variant c.5899C>T (p.Arg1967Ter) is not reported in 1000 Genomes and its minor allele frequency in ExAC databases is 0.00001328. The in silico prediction of the variant is disease causing by MutationTaster2. -
This sequence change creates a premature translational stop signal (p.Arg1967*) in the DMD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DMD are known to be pathogenic (PMID: 16770791, 25007885). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individuals with Duchenne or Becker muscular dystrophy (PMID: 8401539, 18652600, 30833962). This variant is also known as c.6107C>T. ClinVar contains an entry for this variant (Variation ID: 11258). For these reasons, this variant has been classified as Pathogenic. -
- -
Cardiovascular phenotype Pathogenic:1
The p.R1967* pathogenic mutation (also known as c.5899C>T), located in coding exon 41 of the DMD gene, results from a C to T substitution at nucleotide position 5899. This changes the amino acid from an arginine to a stop codon within coding exon 41. This mutation has been detected in muscular dystrophy cohorts (Cunniff C et al. J Child Neurol, 2009 Apr;24:425-30; Takeshima Y et al. J Hum Genet, 2010 Jun;55:379-88; Park HJ et al. Clin Genet, 2017 03;91:403-410; Wang L et al. Front Genet, 2019 Feb;10:114; Okubo M et al. Hum Genet, 2020 Feb;139:247-255). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at